Skip to main content
Log in

Genetisches Risikoprofil der Sarkoidose

Genetic risk profile of sarcoidosis

  • Schwerpunkt
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Die Sarkoidose ist eine multifaktorielle und polygene Erkrankung. Im vorliegenden Beitrag wird der genetische Kenntnisstand dargestellt. Zudem werden die funktionellen Konsequenzen im aktuellen Konzept der Immunpathogenese diskutiert. Es ist zu erwarten, dass sich aus diesen Kenntnissen in naher Zukunft klinisch anwendbare genetische Risikoprofile ergeben werden.

Abstract

Sarcoidosis is a multifactorial and polygenic disorder. The current knowledge of its genetic basis will be presented and functional consequences of the genetic variants that influence the immunopathogenesis of this disorder will be depicted. In the near future it is expected that this knowledge will yield clinically applicable genetic risk profiles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Zissel G, Prasse A, Muller-Quernheim J (2010) Immunologic response of sarcoidosis. Semin Respir Crit Care Med 31:390–403

    Article  PubMed  Google Scholar 

  2. Müller-Quernheim J, Schürmann M, Hofmann S et al (2008) Genetics of sarcoidosis. Clin Chest Med 29:391–414

    Article  PubMed  Google Scholar 

  3. Chen ES, Moller DR (2011) Sarcoidosis – scientific progress and clinical challenges. Nat Rev Rheumatol 7:457–567

    Article  CAS  PubMed  Google Scholar 

  4. Grunewald J, Eklund A, Olerup O (2004) Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 169:696–702

    Article  PubMed  Google Scholar 

  5. Wahlstrom J, Dengjel J, Persson B et al (2007) Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117:3576–3582

    Google Scholar 

  6. Foley PJ, McGrath DS, Puscinska E et al (2001) Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 25:272–277

    Article  CAS  PubMed  Google Scholar 

  7. Valentonyte R, Hampe J, Huse K et al (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37:357–364

    Article  CAS  PubMed  Google Scholar 

  8. Schürmann M, Reichel P, Müller-Myhsok B et al (2001) Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164:840–846

    Article  PubMed  Google Scholar 

  9. Müller-Quernheim J, Schürmann M, Hofmann S et al (2009) Genetik der Sarkoidose: Ein Schlüssel zum Verständnis ihrer Pathogenese. Pneumologie 63:166–175

    Article  PubMed  Google Scholar 

  10. Hofmann S, Franke A, Fischer A et al (2008) Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40:1103–1106

    Article  CAS  PubMed  Google Scholar 

  11. Hofmann S, Fischer A, Till A et al (2011) A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J 38:1127–1135

    Article  Google Scholar 

  12. Hofmann S, Fischer A, Nothnagel M et al (2013) Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis. Eur Respir J 41:888–900

    Article  Google Scholar 

  13. Fischer A, Schmid B, Ellinghaus D et al (2012) A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am J Respir Crit Care Med 186:877–885

    Article  CAS  PubMed  Google Scholar 

  14. Adrianto I, Lin CP, Hale JJ et al (2012) Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One 7:e43907

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Nguyen T, Liu XK, Zhang Y, Dong C (2006) BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 176:7354–7360

    Google Scholar 

  16. Ziegenhagen MW, Muller-Quernheim J (2003) The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253:18–30

    Google Scholar 

  17. Idali F, Wahlstrom J, Dahlberg B et al (2009) Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res 10:42

    Article  PubMed Central  PubMed  Google Scholar 

  18. Seitzer U, Gerdes J, Müller-Quernheim J (2002) Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res 3:6

    Article  PubMed Central  PubMed  Google Scholar 

  19. Spagnolo P, Renzoni EA, Wells AU et al (2003) C-C chemokine receptor 2 and sarcoidosis: association with Lofgren’s syndrome. Am J Respir Crit Care Med 168:1162–1166

    Article  PubMed  Google Scholar 

  20. Valentonyte R, Hampe J, Croucher PJ et al (2005) Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 171:1136–1141

    Article  PubMed  Google Scholar 

  21. Schürmann M, Kwiatkowski R, Albrecht M et al (2008) Study of Toll-like receptor gene loci in sarcoidosis. Clin Exp Immunol 152:423–431

    Article  PubMed Central  PubMed  Google Scholar 

  22. Wei J, Rahman S, Ayaub EA et al (2013) Protein misfolding and endoplasmic reticulum stress in chronic lung disease. Chest 143:1098–1105

    Article  CAS  PubMed  Google Scholar 

  23. Becker ML, Rose CD (2005) Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 7:427–433

    Article  CAS  PubMed  Google Scholar 

  24. Schürmann M, Valentonyte R, Hampe J et al (2003) CARD15 gene mutations in sarcoidosis. Eur Respir J 22:748–754

    Article  Google Scholar 

  25. Rybicki BA, Sinha R, Iyengar S et al (2007) Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun 8:379–386

    Article  CAS  PubMed  Google Scholar 

  26. Prasse A, Katic C, Germann M et al (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177:330–336

    Article  CAS  PubMed  Google Scholar 

  27. Seitzer U, Gerdes J, Müller-Quernheim J (2001) Evidence for disease phenotype associated haplotypes (DR.TNF) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:279–283

    CAS  PubMed  Google Scholar 

  28. Takashige N, Naruse TK, Matsumori A et al (1999) Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 54:191–193

    Article  CAS  PubMed  Google Scholar 

  29. Rybicki BA, Walewski JL, Maliarik MJ et al (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77:491–499

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. A. Fischer, G. Zissel, A. Nebel und J. Müller-Quernheim geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Müller-Quernheim.

Additional information

Diese Arbeit wurde unterstützt durch das Nationale Genomforschungsnetzwerk (01GSS0426) und die Deutsche Forschungsgemeinschaft (MU692/7-1 und 8-1).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fischer, A., Zissel, G., Nebel, A. et al. Genetisches Risikoprofil der Sarkoidose. Internist 55, 135–140 (2014). https://doi.org/10.1007/s00108-013-3308-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-013-3308-6

Schlüsselwörter

Keywords

Navigation